Immunotherapy

Development of novel analytical and diagnostic tools using nanotechnology and microfluidics

Dr Alain Wuethrich is an NHMRC Emerging Leader fellow and ARC DECRA awardee at the Australian Institute for Bioengineering and Nanotechnology.

Hailing from Switzerland, research focuses on the development of novel analytical and diagnostic tools that harness nanotechnology and microfluidics; two rapidly growing fields with high potential to provide diagnostic solutions needed for precision medicine.

Next-generation NK cell-based immunotherapies for hard-to-treat cancers

Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.

Dr Jasmine Kaur

RESEARCH IN IMMUNOTHERAPY
@ GRIFFITH UNIVERSITY
QUEENSLAND, AUSTRALIA

Scroll to top